+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The lack of a leukocyte IL-8 receptor homologue leads to marked inhibition of atherosclerosis in LDL receptor-deficient mice



The lack of a leukocyte IL-8 receptor homologue leads to marked inhibition of atherosclerosis in LDL receptor-deficient mice



Circulation 96(8 SUPPL ): I37, 10/21/97




(PDF emailed within 1 workday: $29.90)

Accession: 033856649

Download citation: RISBibTeXText


Related references

A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. Journal of Clinical Investigation 101(2): 353-363, 1998

Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. Journal of Clinical Investigation 120(11): 3979-3995, 2010

Retraction. Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. Journal of Clinical Investigation 122(3): 1131-1131, 2012

AT1-receptor blockade is at least as effective as ACE inhibition in reducing atherosclerosis in LDL receptor-deficient mice. Circulation 102(18 Supplement): II 318, October 31, 2000

Inhibition of atherosclerosis in LDL receptor deficient mice by endothelin receptor blockade. Circulation 98(17 SUPPL ): I310, Oct 27, 1998

Inhibition of atherosclerosis in LDL-receptor-deficient mice reconstituted with perforin-deficient bone marrow. Circulation 102(18 Supplement): II 114, October 31, 2000

Lack of estrogen in LDL receptor-deficient female mice results in peripheral leukocytosis and atherosclerosis. Circulation 100(18 SUPPL ): I 331, Nov 2, 1999

Lack of I╬║BNS accelerates atherosclerosis in LDL receptor-deficient mice via increased interleukin-6 production. International Journal of Cardiology 211: 61-63, 2016

Gene transfer and hepatic expression of apoE induces regression of advanced atherosclerosis and marked reduction of isoprostanes in LDL receptor deficient mice. Circulation 100(18 SUPPL ): I 692, Nov 2, 1999

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proceedings of the National Academy of Sciences of the United States of America 101(29): 10679-10684, 2004

Liver-derived apoE inhibits progression of atherosclerosis in LDL receptor deficient mice despite lack of effect on plasma cholesterol levels. Circulation 98(17 SUPPL ): I305, Oct 27, 1998

Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. Journal of Clinical Investigation 112(8): 1176-1185, 2003

Overexpression of the human macrophage scavenger receptor reduces atherosclerosis in both low density lipoprotein receptor deficient mice and APOE3Leiden transgenic mice. Circulation 100(18 SUPPL ): I 751, Nov 2, 1999

Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 26(8): 1845-1851, 2006

DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 27(5): 1095-1100, 2007